BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27852227)

  • 1. Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors.
    Pawlak A; Ziolo E; Fiedorowicz A; Fidyt K; Strzadala L; Kalas W
    BMC Cancer; 2016 Nov; 16(1):893. PubMed ID: 27852227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.
    Signore M; Buccarelli M; Pilozzi E; De Luca G; Cappellari M; Fanciulli M; Goeman F; Melucci E; Biffoni M; Ricci-Vitiani L
    Oncotarget; 2016 Jul; 7(28):44113-44128. PubMed ID: 27286453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase.
    Hosokawa M; Seiki R; Iwakawa S; Ogawara KI
    Biochem Biophys Res Commun; 2021 Nov; 578():157-162. PubMed ID: 34571370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
    Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
    Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.
    Damrot J; Nübel T; Epe B; Roos WP; Kaina B; Fritz G
    Br J Pharmacol; 2006 Dec; 149(8):988-97. PubMed ID: 17088865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
    Badinloo M; Esmaeili-Mahani S
    Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schlafen-11 sensitizes colorectal carcinoma cells to irinotecan.
    Tian L; Song S; Liu X; Wang Y; Xu X; Hu Y; Xu J
    Anticancer Drugs; 2014 Nov; 25(10):1175-81. PubMed ID: 25089570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.
    Preet R; Mohapatra P; Mohanty S; Sahu SK; Choudhuri T; Wyatt MD; Kundu CN
    Int J Cancer; 2012 Apr; 130(7):1660-70. PubMed ID: 21544805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic anticancer effect of panobinostat and topoisomerase inhibitors through ROS generation and intrinsic apoptotic pathway induction in cervical cancer cells.
    Wasim L; Chopra M
    Cell Oncol (Dordr); 2018 Apr; 41(2):201-212. PubMed ID: 29260509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective Targeting Survivin, Caspase-3 and MicroRNA-16-1 Expression by Methyl-3-pentyl-6-methoxyprodigiosene Triggers Apoptosis in Colorectal Cancer Stem-Like Cells.
    Sam S; Sam MR; Esmaeillou M; Safaralizadeh R
    Pathol Oncol Res; 2016 Oct; 22(4):715-23. PubMed ID: 27055667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
    Dong YB; Yang HL; Elliott MJ; McMasters KM
    Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
    Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
    J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
    Arnold CN; Goel A; Boland CR
    Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2'-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicin.
    Elliott MJ; Stribinskiene L; Lock RB
    Cancer Chemother Pharmacol; 1998; 41(6):457-63. PubMed ID: 9554589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment.
    Chen S; Gomez SP; McCarley D; Mainwaring MG
    Cancer Chemother Pharmacol; 2002 May; 49(5):347-55. PubMed ID: 11976828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.
    Hurtubise A; Momparler RL
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):618-25. PubMed ID: 16783580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells.
    Chen JC; Hsieh YY; Lo HL; Li A; Chou CJ; Yang PM
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31505885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.
    Perimenis P; Galaris A; Voulgari A; Prassa M; Pintzas A
    BMC Cancer; 2016 Aug; 16():624. PubMed ID: 27520705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.